跳至主要内容
临床试验/EUCTR2020-001366-11-LV
EUCTR2020-001366-11-LV进行中(未招募)1 期

An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care - Solidarity

World Health Organization0 个研究点目标入组 100,000 人开始时间: 2020年5月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
100,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Consenting adults (age =18) hospitalised with definite COVID-19, not already receiving any of the study drugs, and without anticipated transfer within 72 hours to a non-study hospital.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10000
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 90000

排除标准

  • Known allergy or contra-indications to any of study drugs (in the view of the physician responsible for their care).

研究者

相似试验